Christian Stevenson

Dechert LLP

$ $$$

Oliver Street 100
Boston 02110 MA US

Christian P. Stevenson, Ph.D. is a patent agent in the Patent Counseling and Prosecution practice of Dechert’s Intellectual Property group. Dr. Stevenson assists clients with patent application drafting and prosecution in the U.S. and internationally, freedom-to-operate analyses and intellectual property due diligence.

He has experience across a broad range of technologies, including pharmaceuticals, medical devices, drug delivery technologies, chemical processes, biomaterials, agrochemicals and cosmetics.

In addition to his legal experience, Dr. Stevenson is also an accomplished research scientist, having conducted medicinal chemistry and pre-clinical drug discovery at Merck & Co., Inc.  He designed and synthesized novel compounds targeting ion channels, g-protein-coupled receptors and soluble enzymes as potential treatments for diabetes and pain. This work is the subject of numerous issued patents and patent applications.

Dr. Stevenson’s doctoral research focused on the total synthesis of peloruside A, as well as synthetic and mechanistic investigations of the hydrolytic kinetic resolution of terminal epoxides. His research on this subject has been published in peer-reviewed journals, including Journal of the American Chemical Society, Angewandte Chemie and Organic Syntheses.

Prior to joining Dechert, Dr. Stevenson was a scientific advisor at Goodwin Procter and a director of client services at open-innovation and crowdsourcing company, InnoCentive.

EDUCATION :

  • Wake Forest University, B.S., Chemistry and German, 1999, summa cum laude
  • Harvard University, Ph.D., Organic Chemistry, 2005, National Science Foundation Graduate Research Fellowship, Certificate of Distinction in Teaching

ADMISSIONS : United States Patent and Trademark Office

MEMBERSHIPS : American Chemical Society

EXPERIENCE :

  • Lycera Corporation, a pharmaceutical company developing medicines to treat autoimmune disease and cancer, to manage intellectual property matters including development and implementation of strategies to procure patent protection for multiple small molecule therapeutic agents in human clinical trials.
  • Centrexion Therapeutics Corporation, a pharmaceutical company developing medicines to treat pain, to manage intellectual property matters including development and implementation of strategies to procure patent protection for multiple small molecule therapeutic agents in human clinical trials.
  • Rafael Pharmaceuticals, Inc., a pharmaceutical company developing medicines to treat cancer, to manage intellectual property matters including development and implementation of strategies to procure patent protection for small molecule therapeutic agents being developed for treatment of cancer.

Cost

Rate : $$$$

Contact for details

Rate and write a review

Your email address will not be published. Required fields are marked *

Is this your profile?Claim it now.

Make sure your information is up to date.
Oliver Street 100
Boston 02110 MA US
Get directions

Lina Stillman

5.0
Broadway 42
New York 10006 NY US
Advertisement